In last trading session, Apellis Pharmaceuticals Inc (NASDAQ:APLS) saw 2.55 million shares changing hands with its beta currently measuring 0.67. Company’s recent per share price level of $16.36 trading at -$0.34 or -2.04% at ring of the bell on the day assigns it a market valuation of $2.06B. That closing price of APLS’s stock is at a discount of -168.89% from its 52-week high price of $43.99 and is indicating a discount of -0.31% from its 52-week low price of $16.41.
For Apellis Pharmaceuticals Inc (APLS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.83. Splitting up the data highlights that, out of 14 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 11 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Apellis Pharmaceuticals Inc (NASDAQ:APLS) trade information
Upright in the red during last session for losing -2.04%, in the last five days APLS remained trading in the red while hitting it’s week-highest on Friday, 05/09/25 when the stock touched $16.36 price level, adding 9.61% to its value on the day. Apellis Pharmaceuticals Inc’s shares saw a change of -48.73% in year-to-date performance and have moved -8.14% in past 5-day. Apellis Pharmaceuticals Inc (NASDAQ:APLS) showed a performance of -13.76% in past 30-days.
Wall Street analysts have assigned a consensus price target of 76 to the stock, which implies a rise of 78.47% to its current value. Analysts have been projecting 39 as a low price target for the stock while placing it at a high target of 113. It follows that stock’s current price would drop -138.39% in reaching the projected high whereas dropping to the targeted low would mean a loss of -138.39% for stock’s current value.
Apellis Pharmaceuticals Inc (NASDAQ:APLS)’s Major holders
WELLINGTON MANAGEMENT GROUP LLP is the top institutional holder at APLS for having 16.39 million shares of worth $628.67 million. And as of 2024-06-30, it was holding 13.2269 of the company’s outstanding shares.
The second largest institutional holder is ECOR1 CAPITAL, LLC, which was holding about 11.61 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.3681 of outstanding shares, having a total worth of $445.26 million.
On the other hand, VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025, the former fund manager was holding 8.48 shares of worth $138.69 million or 6.75% of the total outstanding shares. The later fund manager was in possession of 3.26 shares on Dec 31, 2024, making its stake of worth around $53.36 million in the company or a holder of 2.60% of company’s stock.
